Nathalie has been working with the European Medicines Agency in London for over 20 years and is currently responsible for its engagement with patients and consumers. Patients bring specific knowledge and expertise from their real-life experience of the condition and its treatment to the scientific discussions, and their contributions have led to better outcomes for everyone involved.
Over the years, she has been dedicated to creating opportunities for the inclusion of the patient’s voice in every aspect of the regulatory lifecycle of a medicine. Experience at EMA has demonstrated that it is essential to be flexible and to test and implement a range of engagement methodologies to best suit the various engagement activities.
As a steady increase in patient engagement at EMA has been observed, Nathalie will look to further strengthen these activities through constant exchanges with stakeholders in order to ensure interactions are as mutually beneficial as possible.
More speakers Announced soon
Please check back later for updates.
We are proud to announce that EPF Congress 2019 is Patients Included™. This means that EPF is committed to incorporating the experience of patients as experts in living with their condition while ensuring they were neither excluded nor exploited.More information
The website you’re trying to visit is from the 2019 edition of the EPF Congress. To get informations for this year’s event please follow the right link below.